Publication | Closed Access

A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A

MedicineMalignant Pleural EffusionsImmunologyPathologyPhase Ii StudyImmune Checkpoint InhibitorPleural DiseaseCancer TreatmentOncologyRadiation OncologyLung Cancer